- Home
- UHT vs CRMD Comparison
UHT vs CRMD Comparison
Compare UHT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHT | CRMD |
|---|---|---|
| Founded | 1986 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 558.6M | 626.0M |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | UHT | CRMD |
|---|---|---|
| Price | $40.49 | $8.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $43.00 | $14.83 |
| AVG Volume (30 Days) | 211.6K | ★ 1.2M |
| Earning Date | 04-27-2026 | 05-11-2026 |
| Dividend Yield | ★ 7.33% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | 0.36 | ★ 0.43 |
| Revenue | $99,190,000.00 | ★ $311,709,000.00 |
| Revenue This Year | $2.12 | $0.30 |
| Revenue Next Year | $2.94 | N/A |
| P/E Ratio | $111.06 | ★ $20.00 |
| Revenue Growth | 0.18 | ★ 617.03 |
| 52 Week Low | $35.26 | $6.13 |
| 52 Week High | $44.70 | $15.12 |
Technical Indicators
Market Signals| Indicator | UHT | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 57.15 |
| Support Level | $39.08 | $8.09 |
| Resistance Level | $41.93 | $9.01 |
| Average True Range (ATR) | 1.24 | 0.32 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 67.76 | 56.64 |
Price Performance
Historical ComparisonAbout UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.